Päivi Pietilä-Effati

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Left Ventricular

Cardiac Resynchronization Therapy

Prognostic Factors

Top Venues

Molecular genetics & genomic medicine

Scandinavian cardiovascular journal : SCJ

American journal of medical genetics. Part A

This page only lists publications with an associated author ORCID identifier.

Publications

Päivi Pietilä-Effati, Jukka T Saarinen, Eliisa Löyttyniemi, Maria Saarenhovi, Reijo Autio, Ilkka Kantola
Long-term effectiveness of enzyme replacement therapy in Fabry disease with the p.Arg227Ter variant: Fabry disease in Ostrobothnia (FAST) study. American journal of medical genetics. Part A (2023)
Päivi Pietilä-Effati, Johan Söderström, Jukka T Saarinen, Eliisa Löyttyniemi, Ilkka Kantola
Pulmonary manifestations and the effectiveness of enzyme replacement therapy in Fabry Disease with the p. Arg227Ter (p.R227*) mutation. Molecular genetics & genomic medicine 10 (5) (2022)
Hanna-Kaisa Nordenswan, Pauli Pöyhönen, Jukka Lehtonen, Kaj Ekström, Valtteri Uusitalo, Meri Niemelä, Tapani Vihinen, Kari Kaikkonen, Petri Haataja, Tuomas Kerola, Tuomas T Rissanen, Aleksi Alatalo, Päivi Pietilä-Effati, Markku Kupari
Incidence of Sudden Cardiac Death and Life-Threatening Arrhythmias in Clinically Manifest Cardiac Sarcoidosis With and Without Current Indications for an Implantable Cardioverter Defibrillator. Circulation 146 (13) (2022)
Päivi Pietilä-Effati, Mathias Höglund, Aki Käräjämäki, Filip Höglund, Anne-Maria Nabb, Eija Matila, M Juhani Koistinen
Renal denervation in patients who do not respond to cardiac resynchronization therapy. Scandinavian cardiovascular journal : SCJ 56 (1) (2022)
Päivi Pietilä-Effati, Jukka T Saarinen, Eliisa Löyttyniemi, Reijo Autio, Maria Saarenhovi, Maria K Haanpää, Ilkka Kantola
Natural course of Fabry disease with the p. Arg227Ter (p.R227*) mutation in Finland: Fast study. Molecular genetics & genomic medicine 7 (10) (2019)